I’m not an expert on this, but haven’t GLP-1’s been used for quite a while on more limited scopes? So maybe there’s a cohort of people that could approach statistical significance.

IIRC, mostly used to help with type 2 diabetes... But effects on that cohort may not generalize to the general population.

This particular study was done on people without diabetes, at least.